Home326030 • KRX
add
SK Biopharmaceuticals Co Ltd
Previous close
₩125,400.00
Day range
₩121,300.00 - ₩125,600.00
Year range
₩72,600.00 - ₩130,000.00
Market cap
9.65T KRW
Avg Volume
415.79K
P/E ratio
285.48
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(KRW) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 134.00B | 73.99% |
Operating expense | 99.20B | 14.59% |
Net income | 28.14B | 220.54% |
Net profit margin | 21.00 | 169.28% |
Earnings per share | — | — |
EBITDA | 30.37B | 296.77% |
Effective tax rate | -3.20% | — |
Balance Sheet
Total assets
Total liabilities
(KRW) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 286.45B | 28.52% |
Total assets | 824.08B | 30.57% |
Total liabilities | 452.56B | 33.33% |
Total equity | 371.52B | — |
Shares outstanding | 78.31M | — |
Price to book | 29.04 | — |
Return on assets | 8.06% | — |
Return on capital | 11.60% | — |
Cash Flow
Net change in cash
(KRW) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 28.14B | 220.54% |
Cash from operations | -6.83B | 75.01% |
Cash from investing | 1.82B | -94.60% |
Cash from financing | -1.06B | 22.08% |
Net change in cash | -4.65B | -262.09% |
Free cash flow | -16.76B | -34.19% |
About
Founded
1993
Website
Employees
241